Replimune Group, Inc.
US ˙ NasdaqGS ˙ US76029N1063

SecurityREPL / Replimune Group, Inc.
InstitutionGeode Capital Management, Llc
Latest Disclosed Ownership1,801,525 shares
Latest Disclosed Value $ 13,785,010
Geode Capital Management, Llc reports 2.93% increase in ownership of REPL / Replimune Group, Inc.

On May 15, 2026 - Geode Capital Management, Llc filed a 13F-HR form disclosing ownership of 1,801,525 shares of Replimune Group, Inc. (US:REPL) valued at $13,781,666 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 1,750,194 shares of Replimune Group, Inc.. This represents a change in shares of 2.93% during the quarter. The current value of the position is $17,979,220 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F REPLIMUNE GROUP COM 76029N106 1,801,525 51,331 2.93 13,785 -18.98 0.0005
2026-02-09 2025-12-31 13F REPLIMUNE GROUP COM 76029N106 1,750,194 54,746 3.23 17,016 139.48 0.0011
2025-11-12 2025-09-30 13F REPLIMUNE GROUP COM 76029N106 1,695,448 71,400 4.40 7,105 -52.91 0.0005
2025-08-08 2025-06-30 13F REPLIMUNE GROUP COM 76029N106 1,624,048 -48,722 -2.91 15,090 -7.50 0.0011
2025-05-13 2025-03-31 13F REPLIMUNE GROUP COM 76029N106 1,672,770 243,104 17.00 16,313 -5.80 0.0013
2025-02-12 2024-12-31 13F REPLIMUNE GROUP COM 76029N106 1,429,666 1,365 0.10 17,318 10.60 0.0013
2024-11-12 2024-09-30 13F REPLIMUNE GROUP COM 76029N106 1,428,301 217,308 17.94 15,657 43.64 0.0013
2024-08-09 2024-06-30 13F REPLIMUNE GROUP COM 76029N106 1,210,993 19,200 1.61 10,901 11.93 0.0010
2024-05-13 2024-03-31 13F REPLIMUNE GROUP COM 76029N106 1,191,793 46,681 4.08 9,739 0.87 0.0009
2024-02-13 2023-12-31 13F REPLIMUNE GROUP COM 76029N106 1,145,112 136,769 13.56 9,654 -44.05 0.0010
2023-11-13 2023-09-30 13F REPLIMUNE GROUP COM 76029N106 1,008,343 207,515 25.91 17,255 -7.21 0.0021
2023-08-11 2023-06-30 13F REPLIMUNE GROUP COM 76029N106 800,828 -26,416 -3.19 18,595 27.28 0.0022
2023-05-15 2023-03-31 13F REPLIMUNE GROUP COM 76029N106 827,244 128,099 18.32 14,609 76,789.47 0.0019
2023-02-13 2022-12-31 13F REPLIMUNE GROUP COM 76029N106 699,145 14,132 2.06 19 -99.84 0.0027
2022-11-14 2022-09-30 13F REPLIMUNE GROUP COM 76029N106 685,013 144,297 26.69 11,830 25.17 0.0018
2022-08-12 2022-06-30 13F REPLIMUNE GROUP COM 76029N106 540,716 -1,583 -0.29 9,451 2.64 0.0014
2022-05-13 2022-03-31 13F REPLIMUNE GROUP COM 76029N106 542,299 17,631 3.36 9,208 -35.24 0.0011
2022-02-11 2021-12-31 13F REPLIMUNE GROUP COM 76029N106 524,668 25,162 5.04 14,218 -3.96 0.0017
2021-11-12 2021-09-30 13F REPLIMUNE GROUP COM 76029N106 499,506 29,712 6.32 14,805 -17.97 0.0020
2021-08-13 2021-06-30 13F REPLIMUNE GROUP COM 76029N106 469,794 37,865 8.77 18,049 36.96 0.0025
2021-05-12 2021-03-31 13F REPLIMUNE GROUP COM 76029N106 431,929 51,037 13.40 13,178 -9.31 0.0020
2021-02-12 2020-12-31 13F REPLIMUNE GROUP COM 76029N106 380,892 90,086 30.98 14,531 117.07 0.0024
2020-11-13 2020-09-30 13F REPLIMUNE GROUP COM 76029N106 290,806 79,343 37.52 6,694 27.41 0.0013
2020-08-13 2020-06-30 13F REPLIMUNE GROUP COM 76029N106 211,463 29,620 16.29 5,254 189.96 0.0011
2020-05-14 2020-03-31 13F REPLIMUNE GROUP COM 76029N106 181,843 16,507 9.98 1,812 -23.61 0.0005
2020-02-20 2019-12-31 13F/A-1 REPLIMUNE GROUP COM 76029N106 165,336 31,580 23.61 2,372 27.60 0.0005
2020-02-13 2019-12-31 13F REPLIMUNE GROUP COM 76029N106 165,336 31,580 2,372 302.2906
2019-11-12 2019-09-30 13F REPLIMUNE GROUP COM 76029N106 133,756 2,437 1.86 1,859 -3.43 0.0004
2019-08-14 2019-06-30 13F REPLIMUNE GROUP COM 76029N106 131,319 17,463 15.34 1,925 11.14 0.0005
2019-05-14 2019-03-31 13F REPLIMUNE GROUP COM 76029N106 113,856 61,169 116.10 1,732 229.28 0.0004
2019-03-06 2018-12-31 13F/A-1 REPLIMUNE GROUP COM 76029N106 52,687 6,878 15.01 526 -28.63 0.0002
2019-02-13 2018-12-31 13F REPLIMUNE GROUP COM 76029N106 52,687 6,878 526
2018-11-13 2018-09-30 13F REPLIMUNE GROUP COM 76029N106 45,809 45,809 737 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.